INTRODUCTION
One of the hallmarks of the adaptive immune system in higher vertebrates is its ability to respond more rapidly and effectively to pathogens that have been previously encountered. The initial observation that clearance of an infection can lead to long-term protection against reinfection with the same or similar pathogens formed the basis for modern vaccination. Clonal selection theory subsequently provided an explanation for this immunological memory by postulating that clonally expanded activated lymphocytes could give rise to a population of long-lived antigenspecific cells capable of protecting the host from reinfection. It has since become clear that in addition to increasing the total number of pathogen-specific cells that can mount a recall response, lymphocyte activation also induces stable transcriptional, epigenetic, and metabolic changes that contribute in a cell-intrinsic manner to the survival and enhanced responsiveness of long-lived memory cells (Chang et al., 2014) .
While the term ''immunological memory'' typically refers to the enhanced ability to protect against re-infection, immune cells may ''remember'' a host of stimuli and prior activations leading to states of altered responsiveness. For example, recognition of self-antigen by CD8 T cells can imprint a state of tolerance, characterized by the persistent inability to respond to cognate antigen even after it is encountered in a highly immunogenic context. This state can be ''remembered'' after cells are removed from the tolerizing environment (Schietinger et al., 2012) . Another example is T cell exhaustion, a state of functional hyporesponsiveness resulting from persistent exposure to antigen and inflammatory signals, best characterized in the context of chronic viral infection (Wherry and Kurachi, 2015) . This exhausted state becomes increasingly irreversible upon long-term exposure to the stimulatory environment and may eventually persist even in the absence of external cues (Angelosanto et al., 2012; Utzschneider et al., 2013) . Importantly, this type of cellular memory of prior activation states is not restricted to the adaptive immune system, but can also influence innate immune cell function in both vertebrate and invertebrate animals. Thus, mechanisms that mediate short-and long-term cellular memory of prior challenges act broadly across cell types and may enable contextdependent fine-tuning of immune responsiveness (Monticelli and Natoli, 2013; Quintin et al., 2014) . The extent to which different immune and non-immune cell types diverge in their ability to maintain a cell-intrinsic memory of physiological challenges, and the content of these ''memories,'' are largely unclear.
Regulatory T (Treg) cells are a specialized subset of immunosuppressive CD4 T cells that express the X chromosomeencoded, lineage-specific transcription factor Foxp3 . Treg cells maintain peripheral tolerance by providing essential suppression of autoreactive CD4 T cells that have escaped negative selection in the thymus. In addition, Treg cells act as critical negative regulators of inflammation in various biological contexts, including infection, metabolic disease, tissue repair, and cancer (Belkaid and Tarbell, 2009; Burzyn et al., 2013) . Importantly, Treg cells respond to inflammation by sharply increasing their suppressive function. Activated Treg cells upregulate immunosuppressive molecules and tissue homing receptors and undergo polycomb-mediated repression of Foxp3-bound genes, which may prevent the acquisition of pro-inflammatory functions . Whether these changes represent stable differentiation or a transient adaptation to the inflammatory environment is currently unclear.
Conventional antigen-specific CD4 and CD8 T cells maintain a large fraction of activation-induced transcriptional changes after pathogen clearance, resulting in increased cytolytic and proinflammatory potential and enhanced responsiveness to cytokine stimulation (Berg et al., 2003; Crawford et al., 2014; Hale et al., 2013; Kaech et al., 2002; Lertmemongkolchai et al., 2001; Sprent and Surh, 2002) . This provides a clear biological benefit to the host by enhancing the ability to respond to previously encountered pathogens to afford protection from re-infection. In contrast, the potential functional importance of an equivalent memory mechanism in Treg cells is not intuitively obvious. Thymic differentiation of Treg cells requires relatively strong T cell receptor (TCR) stimulation, such that the Treg TCR repertoire is enriched for self-reactivity (Hsieh et al., 2004) . A long-lasting increase in the suppressive function of these self-reactive cells, persisting after the resolution of inflammation, may not just negate the benefits of generating effector T cell memory, but could also lead to generalized immunosuppression. Thus, we hypothesized that many inflammation-induced changes in Treg cells, in particular the marked augmentation of their suppressor function, may be transient.
To test this hypothesis, we used inducible genetic lineage tracing to investigate features of Treg cells before, during, or after exposure to an acute inflammatory environment. We found that the inflammation-experienced Treg cell pool reversed many activation-induced transcriptional changes and lost its enhanced suppressive function over time. Transcriptional changes were largely similar during primary and secondary Treg cell activation and not commonly associated with stable chromatin modifications that would facilitate reactivation. In contrast, Treg cell activation induced a limited number of stable changes, including a long-lasting preference for non-lymphoid tissue localization. We found that resting Treg cells shared a transcriptional program with conventional memory T cells, which was not further reinforced upon secondary stimulation. These observations suggest that loss of a ''naïve'' state during Treg cell development may underlie the limited differentiation and memory potential of these cells. Thus, the extent and contents of cellular memory generated in response to transient environmental challenges may markedly differ between closely related cell types based on their developmental history.
RESULTS

Generation and Fate Mapping of InflammationExperienced Treg Cells
T cell memory has traditionally been studied in the context of clonally expanded cells with defined specificities for pathogen-derived or model antigens. Unlike conventional naive CD4 T cells, Treg cells may be viewed as ''antigen-experienced,'' as their generation in the thymus or peripheral lymphoid organs requires strong TCR stimulation. Consistently, Treg TCRs exhibit heightened self-reactivity compared to conventional CD4 T cells. While recognition of non-self-antigens may contribute to Treg cell activation in certain settings (Liu et al., 2014; Shafiani et al., 2013) , it is not clear if TCR-mediated activation is always the sole driver of Treg cell responses. Consistently, TCR-dependent genes account for only a quarter of the activated Treg cellspecific gene signature (Levine et al., 2014) . To study memory of past inflammatory exposures in vivo, we used a model in which Treg cells become activated in response to the widespread inflammatory autoimmune responses that they normally control.
Administration of diphtheria toxin (DT) to Foxp3
GFP-DTR mice results in Treg cell depletion followed by rapid expansion and activation of cytokine-producing effector T cells, granulocytes, and myeloid cells (Kim et al., 2007) . After clearance of DT, Treg cells rebounding in this inflammatory environment acquire an activated phenotype characterized by widespread transcriptional and epigenomic changes and enhanced suppressive function . To track Treg cells over time, we made use of previously described Foxp3
GFP-Cre-ERT2 3 R26Y mice. Treg cells in these mice express a GFP-Cre-ERT2 triple-fusion protein, which undergoes nuclear translocation upon tamoxifen treatment and mediates deletion of a loxp-flanked stop cassette preceding a YFP reporter allele knocked into the Rosa26 locus (Rubtsov et al., 2010) . We generated mixed bone marrow chimeric (BMC) mice by reconstituting irradiated Foxp3 GFP-DTR mice with a 9:1 mixture of Foxp3 GFP-DTR and Foxp3 GFP-Cre-ERT2 3 R26Y bone marrow ( Figure 1A ). In these animals, 90% of the Treg cells can be depleted by DT treatment to induce transient inflammation and a cohort of the remaining Treg cells can be irreversibly labeled to allow isolation of inflammation-experienced YFP + Treg cells after recovery ( Figure 1A ). Transient Treg cell ablation in these mice led to the expansion of activated effector CD4 T cells on day 11 post-treatment ( Figures 1B, 1C , S1A, and S1B Figure 1A ).
Stability of Inflammation-Induced Transcriptional Changes in Treg Cells
Treg cells undergo numerous functional, transcriptional, and epigenomic changes in response to inflammation . To assess the stability of these changes, we first characterized splenic YFP + rTr, aTr, and mTr cell populations by flow cytometry. Compared to rTr cells, aTr cells expressed increased levels of the costimulatory molecules ICOS and GITR, as well as increased levels of Foxp3 (Figures 2A-2C ). These changes were completely or partially reversed after inflammation was resolved (Figures 2A-2C ). In contrast, activation-induced downregulation of the secondary lymphoid tissue homing receptor CD62L and the high-affinity IL-2 receptor a chain CD25 persisted 2 months post-challenge ( Figures 2D and 2E ). These results suggested that Treg cells may maintain only a subset of activation-induced changes.
To account for the stability of activation-induced gene expression changes genome-wide, we performed RNA sequencing (RNA-seq) on bulk rTr and YFP + aTr and mTr cells isolated from mixed BMC mice. We found that 60% of upregulated genes and 43% of downregulated genes had reversed activationinduced expression changes fully or to a significant degree in mTr cells, while 5% and 8% of up-and downregulated genes, respectively, maintained activation-induced changes after resolution of inflammation (Figures 2F-2H Figure 2H ). Previously defined TCR-dependent genes, as well as genes repressed by Foxo1 underwent transient upregulation in response to activation (Figures 2I and 2J) (Levine et al., 2014; Luo et al., 2016) .
Our observations suggested that the bulk Treg cell population had a rather limited capacity to maintain inflammation-induced transcriptional changes. Alternatively, it was possible that autoimmune inflammation in Foxp3 GFP-DTR mice simply did not support formation of functional memory. However, we found that a stable activation-induced gene expression program defined in virus-specific GP66-77/I-A b (GP66) tetramer + CD4 T cells isolated 7 or 75 days after lymphocytic choriomeningitis virus (LCMV) infection was also induced and maintained to a significant degree in inflammation-experienced effector T cells isolated from DT-and tamoxifen-treated Foxp3 Table S2 ). Moreover, these cells maintained a CD44 hi CD62L lo cell surface phenotype and an enhanced capacity to produce IFNg ( Figure S2E ), suggesting that inflammation in the Foxp3 DTR model could support the generation of functional memory cells. To show that the limited maintenance of activation-induced transcriptional changes in mTr cells was not restricted to autoimmune inflammation, we tracked LCMV-experienced Treg cells in tamoxifen-treated Foxp3
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tdTomato animals ( Figure S2F ). Similar to the Foxp3 DTR model, infection-experienced Treg cells were better maintained than their Foxp3 À counterparts in the same mice.
Infection induced a modest upregulation of CD44 and downregulation of CD62L and CD25, which were stably maintained over time (Figures S2G and S2H) . In contrast, many infection-induced transcriptional changes in Treg cells were reversible, including changes in immune response genes such as Gzmb, Ccr5, and Ikzf3 (Figures S2I-S2K; Table S3 ). While the magnitude of (I and J) Activation-induced changes in (I) TCR-, and (J) Foxo1-dependent gene signatures. P values calculated using one-sided Kolmogorov-Smirnov (KS) test comparing signature genes to all genes. Plots are generated using pooled RNA-seq data from two independent experiments (experiment 1: rTr1-3, aTr1-3, mTr1-4; experiment 2: rTr4-5, aTr4-5, mTr5-6). See also Figure S2 and Table S1 .
transcriptional changes was generally much less dramatic, the transient activation program defined in the Foxp3 DTR model was also induced in Treg cells upon LCMV-infection ( Figure S2L ). In contrast, stable expression changes were model-specific (Figure 2M ). Thus, while long term-maintenance and acquisition of a CD44 hi CD62L lo CD25 lo cell surface phenotype may represent common characteristics of activation-experienced Treg cells regardless of the activating stimulus, a limited number of additional stable transcriptional changes may be induced in a response-specific manner. In contrast, regulation of transient activation-induced changes, accounting for a large fraction of transcriptional changes, may be similar in Treg cells responding to different inflammatory challenges.
Maintenance of Inflammation-Induced Chromatin Modifications
While relatively few inflammation-induced transcriptional changes were maintained, it was possible that transiently regulated genes underwent chromatin remodeling that poised them for more rapid or enhanced responses to subsequent challenges. We therefore analyzed the stability of inflammationinduced changes in genome-wide chromatin accessibility and histone modifications indicative of a repressed (H3K27me3), active (H3K27Ac), or poised (H3K4me1) state. Using an assay for transposase accessible chromatin (ATAC-seq) (Buenrostro et al., 2013) , we characterized chromatin accessibility in bulk rTr, YFP + aTr, and mTr cells and identified a total of 1,159 ATAC-seq peaks differentially accessible (false discovery rate [FDR] %5%) in at least one cell type ( Figures 3A and 3B ). ATAC-seq libraries showed the expected pattern of fragmentlength distribution ( Figure S3A ), and accessibility changes measured by ATAC-seq were associated with expression changes in nearby genes ( Figure S3B ). Treg cell activation induced a large number of both transient and stable chromatin accessibility changes ( Figure S3C ) and deposition of permissive and repressive histone modifications in regions flanking accessible sites ( Figures S3D-S3G ). Stable and transient accessibility changes were similarly distributed over promoters, introns, and intergenic regions ( Figure S3H ).
To determine if transient expression changes were associated with stable chromatin-level memory, we performed aggregated analysis of chromatin states based on ATAC-seq and chromatin immunoprecipitation sequencing (ChIP-seq) of aforementioned histone modifications surrounding ATAC-seq peaks (Figures 3C-3E and S4A-S4C; Table S4 ). Chromatin regions associated with transiently upregulated genes became more accessible, gained H3K4me1 and H3K27Ac, and lost H3K27me3 upon Treg cell activation ( Figure 3D ). However, these modifications were lost in inflammation-experienced mTr cells. We observed qualitatively similar changes at stably upregulated genes; however, in accordance with their expression pattern, chromatin changes were stably maintained ( Figure S4B ). Importantly, stably upregulated genes underwent quantitatively greater changes in chromatin accessibility than transiently upregulated genes, suggesting that overall, stable chromatin changes may have been easier to detect. Regulatory elements of transcriptionally repressed genes showed decreased accessibility and H3K27Ac and accumulated H3K27me3 upon Treg cell activation (Figures 3E and S4C) . At transiently downregulated genes these changes were completely lost two months after challenge ( Figure 3E ). In contrast, stable transcriptional repression was associated with a persistent loss of H3K27Ac and gain in H3K27me3 and a continuing decline in accessibility ( Figure S4C ). Thus, stable and transient changes in gene expression were associated with quantitatively or kinetically distinct modifications of chromatin. Critically, our results suggest that genes undergoing transient expression changes upon Treg cell activation do not commonly maintain memory at a chromatin level.
We next analyzed the stability of activation-induced H3K27me3 at Foxp3-bound sites. Foxp3 targets are largely unchanged in activated, compared to resting, Treg cells; however, a subset of these sites acquires activation-induced H3K27me3. This process is Foxp3-dependent and accounts for a large fraction of aTr cell-specific H3K27me3 . As previously reported, Treg cell activation led to increased H3K27me3 deposition at peaks and domains near Foxp3-bound sites (Figure 4A) and this effect was greatest for regions associated with highly bound Foxp3 targets ( Figure 4B ). Moreover, regions in closer proximity to highly bound Foxp3 targets showed the greatest gain in H3K27me3 upon Treg cell activation ( Figure 4C ). Importantly, activation-induced changes in H3K27me3 were completely reversed in the inflammation-experienced mTr cell population ( Figures 4A-4C ).
Reactivation of Inflammation-Experienced Treg Cells
While our results suggested that Treg cells stably maintained only few activation-induced transcriptional and epigenomic changes, it remained possible that the transiently responding gene set maintained certain epigenetic marks not accounted for in our study and was poised to mount a ''recall'' or ''memory'' response upon secondary stimulation. Moreover, stable chromatin modifications could be maintained at distal regulatory elements that were functionally important, but could not be readily linked to the genes undergoing transient expression changes. Finally, it was possible that the bulk population of inflammation-experienced Treg cells contained only a small subpopulation of ''memory'' cells. This subpopulation would not be detectable by a population-based biochemical assay such as RNA-seq, but would preferentially expand and respond differentially to secondary activation.
To account for these possibilities, we compared Treg cell responses to primary and secondary inflammatory challenges. We adoptively transferred rTr cells together with inflammationexperienced mTr cells and congenically marked pre-activated CD4 effector T cells into T cell-deficient mice, so that the primary and secondary responses of Treg cells to inflammation could be directly compared in the same environment ( Figure 5A ). Importantly, recipient mice receiving activated effector T cells alone showed severe weight loss and uncontrolled effector T cell proliferation, indicating that Treg cells in this setting were actively preventing autoimmune inflammation. We isolated cells 2 weeks post-transfer based on expression of fluorescent protein reporters and congenic markers ( Figure 5B ) and analyzed their transcriptional responses by RNA-seq.
We first analyzed the responses of sets of genes that we identified as transiently and stably changed in response to inflammation ( Figure 2G ). Many transcriptional changes resulting from transient Treg cell depletion in the mixed BMC setting were also induced in the adoptive cell transfer model (Figures 5C-5F ; Table S5 ). Strikingly, genes undergoing transient activationinduced expression changes, including TCR-dependent genes, were almost identically affected during primary or secondary activation ( Figures 5D-5F ). In contrast, the few stable transcriptional changes induced by Treg cell activation in the mixed BMC model ( Figure 2G ) were maintained or reinforced during a secondary challenge ( Figure S5A ). Moreover, statistically significant gene expression changes identified in Treg cells undergoing secondary versus primary activation were already present to an extent in mTr cells prior to transfer (Figures S5B and S5C) . To determine if recall responses to viral infection were similarly regulated, we transferred CellTrace-labeled Tomato + mTr cells isolated 60 days after LCMV infection of Figure 5G ). A second group of mice received polyclonal Tomato + LCMV-experienced effector cells (''mTe'') together with naive CD4 T cells prior to infection. When we analyzed the recall expansion of LCMV-experienced cells on day 11 postinfection (p.i.), we found that LCMV-experienced effector cells had proliferated dramatically more than cotransferred naive CD4 T cells ( Figure 5H ). In contrast, LCMV-experienced Treg cells and their inexperienced counterparts proliferated to a similar extent. Compared to primary responders, both Treg and Teff cells undergoing secondary activation showed increased expression of CD44, CXCR3, and reduced expression of CD62L ( Figures 5I and 5J ), although differences were generally smaller in Treg cells. Additionally, Treg cells downregulated CD25. Importantly, these phenotypic changes were already initiated to some degree in LCMV-experienced Treg cells prior to transfer ( Figures S2G and S2H) . Together, our observations suggest that the Treg cell pool responds in a largely similar way to primary and secondary activation by either autoimmune inflammation or viral infection. Nevertheless, Treg cell activation can induce a limited degree of stable differentiation, which may be reinforced upon secondary stimulation. Importantly, these results do not argue against the notion that small subsets of Treg cells with stably altered phenotype or function may differentiate in response to inflammation or infection. However, our observations would suggest that such cells might not be able to undergo pronounced recall expansion to the same extent as conventional memory CD4 T cells.
Treg Cell Activation Transiently Potentiates Suppressive Function, but Confers Lasting Preference for Non-lymphoid Tissue Localization
We next sought to characterize the stability of inflammationinduced changes in Treg cell function. First, we assessed the suppressive capacity of rTr, aTr, and mTr cells on a per-cell basis by measuring their ability to suppress effector T cell proliferation in vitro. As previously reported, aTr cells showed enhanced suppressive function compared to their resting counterparts (Figure 6A ) . Consistent with the predominantly transient changes in expression of genes encoding proven and putative mediators of suppression and related molecules, such as Granzyme B, Galectin-1, Furin, and Fgl2, the suppressor function of mTr cells was equivalent to that of rTr cells. To compare long-term suppressive function in vivo, we transferred pre-activated CD4 effector T cells, alone, or in combination with either rTr or mTr cells into T cell-deficient recipients and monitored weight loss over time as a measurement of autoimmune wasting disease. Because rTr and mTr cells undergo rapid (legend continued on next page) activation under lymphopenic conditions and effectively become activated or reactivated Treg cells, respectively ( Figures 5C  and 5D ), we excluded the aTr cells from this experiment. Consistent with their comparable in vitro suppressor function, rTr and mTr populations were equally capable of preventing effector T cell expansion and wasting disease in this model ( Figures 6B  and 6C ). Together, our data suggest that Treg cells respond to an inflammatory environment by sharply, but transiently increasing their capacity to suppress until inflammation is resolved. This ''memory-less'' potentiation of Treg cell suppressor function may help avoid immunosuppressed states that could otherwise result from repeated inflammatory insults, including infections. Because the small subset of genes undergoing stable activation-induced expression changes was enriched for genes involved in cell migration, adhesion, and extravasation (Figure 6D) , we reasoned that inflammation-experienced Treg cells might have an altered ability to localize to primary and secondary lymphoid organs compared to their inexperienced counterparts. To test this idea, we analyzed the tissue distribution of resting and inflammation-experienced Treg cells 2 weeks after co-transfer into lymphopenic mice in the presence of pre-activated effector CD4 T cells ( Figure 5A ). In mice that received a mix of rTr and aTr cells, aTr cells preferentially accumulated in the intestinal lamina propria, liver, and lung, relative to the spleen and lymph nodes ( Figure 6E ). In mice receiving a mix of mTr and rTr cells, we observed a similar trend ( Figure 6E ). Thus, exposure to an inflammatory environment imprints a stable non-lymphoid tissue localization preference. This observation is consistent with the downregulation of CD62L and CD25 on mTr compared to rTr cells, which may be indicative of a reduced non-lymphoid tissue homing potential and reduced dependency on IL-2, respectively (Smigiel et al., 2014) . Together, our data suggest that activation under inflammatory conditions transiently enhances Treg cell suppressive function and promotes Treg cell localization to non-lymphoid tissues, where they may carry out specialized (G) Experimental design schematic to compare recall responses of LCMV-experienced Treg and Teff cells. Polyclonal mTe and mTr populations were isolated 60 days after LCMV infection and tamoxifen treatment of Foxp3
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tdTomato mice (see Figure S2F ) and mixed at equal ratios with Tomato À naive CD4 (rTn) or rTr cells, respectively. Cells were labeled with CellTrace and transferred into congenically marked, LCMV-infected recipients.
(H-J) FACS analysis of (H) CellTrace, (I) CD44 and CD62L, and (J) CD25 and CXCR3 staining on day 11 p.i. *p < 0.05; **p < 0.01. P values calculated using t test. Error bars show mean with SEM. Representative of two (I and J) or three (H) independent experiments. See also Figure S5 and Table S5 . (legend continued on next page) functions in response to local cues and engage in tissue protection and repair (Panduro et al., 2016) .
Treg and Conventional Memory T Cells Share a Gene Expression Signature Not Stably Affected by Secondary Activation Based on our observations, the Treg cell pool appeared to have a relatively limited ability to maintain activation-induced transcriptional, epigenomic, and functional changes. Our recent finding that Foxp3 represses the expression of several transcriptional regulators implicated in memory T cell development, including TCF1 and OcaB, and can displace another important regulator of memory T cell differentiation, Foxo1, on chromatin, raised the possibility that in Treg cells Foxp3 expression may prevent memory cell differentiation Samstein et al., 2012) . To test this notion, we transferred either aTr cells isolated 11 days after DT treatment of Foxp3 GFP-DTR mice or activated cells expressing a Foxp3-GFP reporter null allele (Foxp3 GFPKO )
into lymphoreplete mice and analyzed maintenance of their activation program 1 month later. Compared to ''fate-mapped'' Treg cells in the BMC setting, aTr cells parked in lymphoreplete hosts maintained a greater fraction of activation-induced changes ( Figures S6A and S6B ). This difference may be due to the stronger activation stimulus induced by complete Treg ablation in Foxp3 GFP-DTR mice compared to 90% Treg ablation in the mixed BMC setting or to the shorter recovery time following transfer. Nevertheless, expression changes in many immune response genes, including Ccr2, Granzyme B, Galectin-3, and Tim-3 were already completely or partially reversed ( Figure S6B ). Importantly, Foxp3-independent activation-induced gene expression changes were maintained or reverted to an equal extent in both aTr cells and Foxp3 GFPKO cells 1 month posttransfer (Figures S6C and S6D ; Table S6 ), arguing against a non-redundant role for Foxp3 in preventing or erasing memory. Because Treg cells are selected for self-reactivity, even Treg cells in naive animals may have been exposed to their cognate antigens. Consistently, a substantial fraction of Treg cells from adult mice has an antigen-experienced CD44 + CD62L À cell surface phenotype ( Figure S2G ) and is long-lived (Luo et al., 2016) . This raises the interesting possibility that a large fraction of the resting Treg cell pool in unmanipulated mice may be composed of cells that are more akin to conventional memory than to naive T cells and this feature may underlie their limited ability to ''remember'' inflammatory stimuli. A corollary of this hypothesis is that T cells should have a limited ability to accumulate stable changes in response to repeated stimulation. While intuitively sound, this notion seemed unlikely at first, given that memory CD8 T cells exposed to multiple rounds of in vivo antigen stimulation were shown to accumulate more and more stable transcriptional changes with each successive activation episode in an almost linear manner (Wirth et al., 2010) . However, the side-by-side comparison of LCMV-specific memory CD4 T cells exposed to either one or two rounds of infection showed that secondary memory CD4 T cells had only limited capacity to further upregulate activation markers ( Figures 7A-7E ) or increase cytokine production in response to in vitro stimulation ( Figure 7F) . Finally, the transcriptomes of primary and secondary memory CD4 T cells were largely similar with only a small fraction of activation-induced changes stably reinforced upon secondary activation (Figures 7G-7I ; Table S7 ). Critically, we found that a large portion of the differentially expressed (FDR <5%, fold change [FC] >2) gene signature identified in Treg cells compared to naive CD4 T cells was also present in conventional memory CD4 T cells ( Figure 7J ), and these genes were not stably up-or downregulated upon secondary memory T cell stimulation ( Figure 7K ). Together, these observations suggest that in contrast to CD8 T cells, antigen-experienced CD4 T cells have a very limited ability to undergo long-lasting transcriptional changes in response to secondary stimulation and this feature may underlie the limited memory ''potential'' of the resting Treg cell pool.
DISCUSSION
Cellular differentiation is associated with changes in gene expression induced in precursor cells by cell-intrinsic or cellextrinsic cues and maintained in mature cells in the absence of the inducing signals. In addition to developmental processes, the ability to ''remember'' exposure to environmental cues can profoundly affect the function of differentiated cells. Such memory of previous challenges features prominently in the immune system. Through genetic fate mapping combined with analysis of transcriptional, epigenomic, and functional changes we found that the bulk population of inflammation-experienced Tregs maintained only a limited subset of inflammation-induced changes, enabling their preferential accumulation in nonlymphoid organs after adoptive transfer. Non-lymphoid tissue Treg cells may acquire specific functions in response to local cues, for example, a tissue protective function mediated by Treg cell-derived amphiregulin (Arpaia et al., 2015 . Genes differentially expressed in Treg compared to Tn (FDR <5% and FC >2) are highlighted. Number of significantly (FDR <5%) up-or downregulated Treg-signature genes is shown. **p < 0.01; ****p < 0.0001. P values were calculated using one-way ANOVA (C-F) with Tukey's multiple comparisons test or chi-square test (J and K). See also Figure S6 and Table S7. possible that chronic exposure to activation signals could eventually imprint a more stable hyper-suppressive state.
Although the effect of overall strength of inflammation and activation signals on the stability of gene expression changes remains unknown, it seems likely that stronger TCR stimulation in response to completely novel antigens or to previously encountered antigens, whose expression is markedly increased upon infectious challenge or injury, may increase the extent of stable differentiation or ''memory'' in Treg cells.
We propose that a largely ''memory-less'' potentiation of Treg cell suppressor function may help avoid not only enhanced suppression of effector memory T cells during a secondary challenge, but also generalized immunosuppression, which may otherwise result from repeated Treg cell activation. While selectively enforcing maintenance of an activated state in inflammation-experienced Treg cells is not technically feasible, published and unpublished observations support the notion that maintaining Treg cells in a perpetually activated or ''super-suppressive'' state long-term may be undesirable. For example, while Foxo1 inactivation is required for Treg cell activation, its genetic deletion results in Treg cell dysfunction (Ouyang et al., 2012) . Additionally, we have observed that a stable gain in suppressor function due to continuous Treg cell-restricted activation of STAT5 results in diminished immune responses to bacterial and viral infections (A.Y.R., T. Chinen, A. Kannan, A. Levine, X. Fan, U. Klein, Y. Zheng, G. Gasteiger, Y. Feng, and J. Fontenot, unpublished data). However, a different form of immune regulatory memory driven by clonal expansion of small populations of antigen-specific Treg cells is likely important in certain contexts and may ensure tolerance to tissue restricted self-antigens, pregnancy associated alloantigens, or antigens from food and commensal microbiota (Lathrop et al., 2011; Legoux et al., 2015; Rosenblum et al., 2011; Rowe et al., 2012) .
Our findings that Treg cells and T effector cells differ in both the extent and the content of ''memory'' of inflammation likely extend to other cell types. We propose that a distinct capacity to maintain a cellular ''memory'' of environmental challenges may be found in other closely related immune cells, such as monocyte-derived macrophages versus tissue resident macrophages, based on their divergent developmental history. We further speculate that cell types characterized by continuous generation from undifferentiated precursors are likely to display pronounced ''memory'' of gene expression and functional changes induced by transient environmental challenges, while those largely maintained via self-renewal may have only a limited ability to ''remember. ' 
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CreERT2 R26 tdTomato mice, we injected animals with DT, followed by tamoxifen treatment on day 7 and 8 post-challenge. Activated and inflammationexperienced effector T cells were FACS-sorted based on expression of tdTomato and lack of GFP expression on day 11 and day 60 post-DT, respectively. Resting effector cells were isolated based on the same criteria from mice receiving tamoxifen only. Comparison of Primary and Secondary Memory of LCMV-Infection GP66 tetramer + CD4 T cells were isolated from LCMV-infected animals on day 60 p.i., and 1 3 10 4 cells were transferred into congenically marked recipients infected with LCMV 1 day post-transfer. Primary and secondary memory cells were isolated 60 days p.i. and were compared by flow cytometry and RNA-seq. For in vitro restimulation, cells were incubated with GP61-80 peptide for 6 hr at 37 C in the presence of brefeldin A.
Adoptive Transfer
In Vitro Suppression Assay
Treg cell populations and naive CD4 T responder cells were cultured at various ratios in the presence of irradiated splenocytes and soluble anti-CD3 antibody (1 mg/ml) for 72 hr. Responder cell proliferation was measured by incorporation of 3 H-thymidine during the final 8 hr of culture.
In Vivo Suppression Assay
Pre-activated effector CD4 T cells (4 3 10 5 ) isolated from Foxp3 GFP-DTR Ly5.1 on day 11 post-DT treatment were transferred together with 1 3 10 5 tdTomato + Treg cells isolated from Foxp3 GFP-DTR CD4 CreERT2 R26 tdTomato mice into TCRbd À/À recipients. Effector T cell numbers in lymphoid and non-lymphoid tissues were analyzed 50 days post-transfer and weight was monitored throughout the experiment.
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